A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis

Scand J Gastroenterol. 2010 Nov;45(11):1360-71. doi: 10.3109/00365521.2010.497938. Epub 2010 Jun 21.

Abstract

Objective: There is no animal model that displays the features of non-alcoholic steatohepatitis (NASH) characterized by insulin resistance (IR) and fibrosing steatohepatitis. This study aimed to develop a novel IR-associated rat model of NASH.

Material and methods: Male Sprague-Dawley rats were fed with the high-fat diet (HFD) supplemented with 0.25% propylthiouracil for 2, 4, 6, 8 and 12 weeks. The IR-associated metabolic parameters, histological assessment and the expression of key insulin signaling molecules were determined. The circulating and tissue pro-inflammatory factors and adipocytokines were examined.

Results: In the HFD-fed rats, the systemic and multiple-organ IR was developed after 4 weeks, whereas the histological changes characterized by steatohepatitis, inflammatory response in the visceral adipose tissue and proliferative pancreatic islet β-cells appeared after 6 weeks, concomitant with altered expression of key insulin signaling molecules. In addition, the elevated levels of serum tumor necrosis factor α (TNF-α), soluble TNF receptor2, interleukin (IL)-6, CC-chemokine ligand (CCL)2 and resistin were parallel with the severity of hepatic inflammation, while the levels of serum adiponectin, leptin and TNF-α, but not resistin, were correlated with IR.

Conclusions: We have developed a systemic IR-associated NASH model of rats, with impaired insulin signaling, systemic inflammation and appropriate pathology characterized by human NASH, and provided a realistic experimental model for elucidating the association between IR and the pathogenesis of NASH.

Publication types

  • Comparative Study

MeSH terms

  • Adiponectin / blood*
  • Adiponectin / genetics
  • Animals
  • Chemokines / genetics
  • Chemokines / metabolism*
  • Disease Models, Animal
  • Disease Progression
  • Fatty Liver / complications
  • Fatty Liver / metabolism*
  • Fatty Liver / pathology
  • Gene Expression Regulation
  • Hepatitis / complications*
  • Hepatitis / metabolism
  • Hepatitis / pathology
  • Insulin Resistance*
  • Leptin / blood*
  • Leptin / genetics
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology
  • Male
  • Polymerase Chain Reaction
  • RNA / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Resistin / metabolism
  • Severity of Illness Index

Substances

  • Adiponectin
  • Chemokines
  • Leptin
  • Resistin
  • RNA